AIFM2 and cancer: A recent study has reported that the expression of the mitochondrial apoptosis inducing factor 2 (AIFM2) can compensate for the function of GPX4 in the human GPX4 deletion cancer cells, and it has been renamed as the FSP1 since it can inhibit ferroptosis without the involvement of GPX4 [84].